Assuntos
Antiasmáticos , Asma , Interleucina-5 , Humanos , Asma/tratamento farmacológico , Asma/diagnóstico , Interleucina-5/antagonistas & inibidores , Volume Expiratório Forçado , Antiasmáticos/uso terapêutico , Resultado do Tratamento , Masculino , Feminino , Eosinofilia/tratamento farmacológico , Eosinófilos/imunologia , Eosinófilos/metabolismo , Pessoa de Meia-Idade , Adulto , Índice de Gravidade de DoençaRESUMO
Various phenotypes of obstructive sleep apnea (OSA) have been recently described and are poorly assessed by the commonly used polysomnographic indices, such as the apnea-hypopnea index and oxygen desaturation index. Nocturnal hypoxemia is the hallmark of OSA and new quantitative markers, as hypoxic burden or desaturation severity, have been shown to be associated with cardiovascular (CV) mortality. The purpose of this overview is to review the endophenotypical and clinical characteristics of OSA, the current metrics, and to analyze different measurements of hypoxemia in OSA to predict the cardiovascular impact (eg hypoxic burden). Potential interest of multidimensional models to classify OSA, such as BAVENO classification, is also discussed, with the goal of focusing on specific endophenotypes that are likely to develop CV comorbidities, in order to guide clinicians to more aggressive management of OSA in these individuals.